...
首页> 外文期刊>Asian Journal of Pharmaceutical Sciences >IL12?–?Study on the targets and mechanisms of traditional Chinese medicine in inhibiting platelet aggregation
【24h】

IL12?–?Study on the targets and mechanisms of traditional Chinese medicine in inhibiting platelet aggregation

机译:IL12?-中药抑制血小板聚集的靶点及作用机制研究

获取原文
           

摘要

Platelets aggregation and thrombosis formation are majorreasons of cardiovascular and cerebral vascular diseases.To develop novel, effective and safe agents for inhibitingplatelet aggregation and preventing above diseases isurgently needed. Some traditional Chinese medicinesfor “Houxue Huayu” have been shown to inhibit plateletaggregation potently. They are used frequently in Chinaand also in Asian countries. Recently, the major effectivecomponents of Pueraria lobata, Salvia miltiorrhiza Bunge,Apium graveolens L. and so on were studied. The mechanismsand the molecular targets of puerarin, salvianolic acid B andthe analogue of 3-n-butylphthalide, dl-PHPB were investigated.Four platelet aggregation inducers, ADP, arachidonicacid (AA), collagen (Col) and thrombin, were used in thestudy.
机译:血小板聚集和血栓形成是心血管和脑血管疾病的主要原因。迫切需要开发新颖,有效,安全的抑制血小板聚集和预防上述疾病的药物。已显示一些用于“厚血化瘀”的中药有效抑制血小板聚集。它们在中国和亚洲国家中经常使用。近年来,研究了葛根,丹参,山茱A等的主要有效成分。研究了葛根素,丹酚酸B和3-正丁基邻苯二甲酸酯类似物dl-PHPB的作用机理和分子靶点。研究了四种血小板聚集诱导剂ADP,花生四烯酸(AA),胶原蛋白(Col)和凝血酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号